Study shows that even breast cancers with few androgen receptors benefit from anti-an

[News]

A University of Colorado Cancer Center study published today in the journal Molecular Cancer Therapeutics shows that only about 1 percent of triple-negative breast cancer cells in a tumor must be "androgen-receptor-positive" to show benefit from anti-androgen therapies.

More... (http://www.news-medical.net/news/20150225/Study-shows-that-even-breast-cancers-with-few-androgen-receptors-benefit-from-anti-androgen-therapy.aspx)